United Imaging Intelligence Unveils Latest Medical AI Solutions at ECR 2024
At ECR 2024 in Vienna, United Imaging Intelligence (UII), a subsidiary of United Imaging Group, unveils its latest advances in medical AI technology.
UII introduces uAI SAT, an innovative AI-driven annotation tool based on a large medical image model that enhances intelligent interactive segmentation, significantly reducing annotation times from hours to merely minutes.
The uAI Pioneer Portal, with its advanced 3D preoperative planning applications tailored for thoracic, hepatobiliary, and urological surgeries, features one-click functionality for diagnostic-level 3D reconstruction of lesions and organs. Coupled with a gesture-controlled 3D monitor, this technology enables users to engage with virtual reality and manipulate detailed models via hand gestures, eliminating the need for 3D goggles or helmets. It offers clinicians an immersive and intuitive visualization of a patient’s preoperative plan and intraoperative anatomy.
UII also showcases a collection of clinical solutions for neurology, cardiology, thoracic and oncology. Among the many breakthroughs, CE mark certification for specific AI applications within UII’s thoracic solutions, including uAI Discovery Pulmonary Nodules, uAI Discover Pneumonia and uAI Discover Fracture, underscored UII’s commitment to healthcare innovation. Using a single chest CT scan, the Thoracic solution provides an assessment of over ten common thoracic conditions, effectively minimizing radiation exposure and patient waiting time.
In neurology, UII’s AI solutions cover the entire continuum of stroke management, from acute care to research. Recognizing the critical nature of timely intervention in stroke management, UII has developed CT-based AI models that enable rapid and accurate identification of strokes, thereby streamlining the treatment workflow.
According to the WHO, cardiovascular disease is a leading cause of death worldwide, claiming an estimated 17.9 million lives each year. UII’s comprehensive cardiac imaging solutions have become indispensable. By integrating assessments from both CT and MRI, UII’s cardiovascular solutions provide detailed analysis of anatomical, functional and tissue characteristics, optimizing image post-processing and significantly reducing the time required for diagnosis.
Finally, UII’s commitment to oncology is also demonstrated by its comprehensive suite of applications covering imaging, screening, diagnosis and treatment for a variety of cancers, including lung, prostate, breast and metastatic disease.
UII believes that medical AI is a critical catalyst that will propel radiology into a new era of transformation. Having deployed its innovative products in more than 3,000 medical institutions worldwide and established research and product collaborations in Europe, UII remains steadfast in its mission to further expand development and partnerships across the region, striving to make the benefits of medical AI universally accessible.
